Crescent Biopharma, Inc. (CBIO): Operating Income
-$152.63M
Year ended 2025-12-31
-$168.47M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$152.63M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$40.04M | n/m | 2025-02-13, From 2024-01-01 |
| 2023-12-31 | -$39.28M | n/m | 2025-02-13, From 2023-01-01 |
| 2022-12-31 | -$47.40M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$63.45M | n/m | 2024-03-27, From 2021-01-01 |
| 2020-12-31 | -$51.51M | n/m | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | -$61.39M | n/m | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | -$51.50M | n/m | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | -$33.93M | n/m | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | -$31.91M | n/m | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | -$12.78M | n/m | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | -$11.14M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$10.61M | n/m | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $3.64M | n/a | 2015-03-16, From 2012-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | -$152.63M | n/m |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$45.91M | n/m |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | -$157.67M | n/m |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | -$383.06M | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$104.57M | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$110.51M | n/m |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | -$214.64M | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $231.0K | n/m |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$267.0K | n/m |
Compare CBIO, JAGX, JANX, ZBIO side by side · Screen every company in Pharmaceutical Preparations ↗